Advertisement

Topics

Adamas Pharma secures approval for Parkinson's dyskinesia drug

18:10 EDT 24 Aug 2017 | Reuters

(Reuters) - The U.S. Food and Drug Administration (FDA) said it had approved Adamas Pharmaceuticals Inc's treatment for a side effect caused by a commonly prescribed Parkinson's drug, sending the shares of the drugmaker soaring in after-market tradin...

Original Article: Adamas Pharma secures approval for Parkinson's dyskinesia drug

NEXT ARTICLE

More From BioPortfolio on "Adamas Pharma secures approval for Parkinson's dyskinesia drug"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Drug Approvals
In order to become availible to pateints, drugs need to undergo a number of phases of clinical trials to test their efficacy and safty and to then be authorised by the drug approval organistion in each respective country. This is the FDA in the USA and N...

Parkinson's Disease
Parkinson's is a progressive neurological condition, affecting one person in every 500, 95% of which are over 40. It is caused by degeneration of more than 70% of the substantia nigra, which depletes the dopamine (the neurotransmitter involved in pro...